Allianz Asset Management GmbH - TRAVERE THERAPEUTICS INC ownership

TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 172 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of TRAVERE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$2,653,000
+61.6%
109,513
+71.9%
0.00%
+200.0%
Q1 2022$1,642,000
-11.3%
63,720
+6.5%
0.00%0.0%
Q4 2021$1,851,000
+407.1%
59,820
+308.7%
0.00%
Q1 2021$365,000
-84.0%
14,635
-82.5%
0.00%
-100.0%
Q4 2020$2,279,00083,6200.00%
Other shareholders
TRAVERE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,084,300$15,820,0003.32%
ARMISTICE CAPITAL, LLC 5,748,000$83,863,0001.50%
RA Capital Management 5,614,428$81,915,0001.32%
Krensavage Asset Management, LLC 140,000$2,043,0000.69%
CM Management, LLC 60,000$875,0000.63%
Altium Capital Management LP 170,484$2,487,0000.58%
HighVista Strategies LLC 53,498$781,0000.55%
Sio Capital Management, LLC 150,000$2,189,0000.54%
MANGROVE PARTNERS IM, LLC 295,037$4,305,0000.44%
Rock Springs Capital Management LP 1,494,164$21,800,0000.43%
View complete list of TRAVERE THERAPEUTICS INC shareholders